Study of the Validity and Reliability of Two Digital Dynamometers in Older People (SOVARDDIOP)

December 10, 2025 updated by: Luis Polo Ferrero, University of Salamanca
It is a cross-sectional, randomized, and single-center study with a duration of 6 months. The study will follow the STROBE guidelines for cross-sectional studies and CONSORT 2024. The main objective is to evaluate the validity and reliability of two devices in measuring grip strength and muscle fatigability in community-dwelling older adults.The study will include community-dwelling older adults of both sexes over 60 years of age.

Study Overview

Status

Completed

Detailed Description

Design: It is a cross-sectional, randomized, and single-center study with a duration of 6 months. The study will follow the STROBE guidelines for cross-sectional studies and CONSORT 2024. The main objective is to evaluate the validity and reliability of the Device 1 and Device 2 devices in measuring grip strength and muscle fatigability in community-dwelling older adults.

It will be carried out in two stages: In a first moment the criterion and interobserver validity will be assessed and in a second moment the intraobserver validity. Participants will be randomly assigned to one of the 6 arms to follow different orders of the devices (Device 1, Device 2 or Jamar).

Population: community-dwelling older adults of both sexes over 60 years of age.

Procedures: The investigators will schedule each participant for the initial assessment day. Using a table of random numbers, they will be assigned one of the arms. All participants have previously read, signed and given their written informed consent. An interview will be conducted in which age, sex and medication will be collected; an anthropometric and functional assessment will be performed. The functional tests include the 30-second squat test and grip strength tests using the Jamar, Device 1 and Device 2. Three repetitions will be performed with each device, allowing 30 seconds between repetitions and 3 to 5 minutes between devices. After 20 minutes the test will be repeated again on the devices for interobserver validation. 5 to 10 days later, tester 1 will repeat the grip test with the same effort to assess intraobserver reliability.

Sample size: Similar studies validating grip strength devices compared to the Jamar showed an excellent correlation (ICC > 0.90). With an estimated ICC of 0.90 ± 0.05 and an alpha risk of 5%, 348 participants are required for the training study.

Variables: Sociodemographic (age, sex, hand dominance, number of medication types), anthropometric (height, weight, BMI and SMI), strength and fatigability (total number of repetitions in 30sCS, maximal grip strength (HGS), fatigue resistance (FR) and grip work (GW)) and device preference.

Statistical analysis: Maximal strength and fatigability will be analyzed by means of means, standard deviations and statistical tests. Concordance between devices will be assessed using the Kappa coefficient and the Bland-Altman concordance index. ROC curves will be used to determine sensitivity and specificity, and data will be analyzed by gender. Results will be considered statistically significant if p < 0.05, and IBM SPSS Statistics v28.0 will be used for analysis.

Study Type

Observational

Enrollment (Actual)

413

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Salamanca
      • Salamanca, Salamanca, Spain, 37007
        • University of Salamanca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Community-dwelling older adults of both sexes over 60 years of age.

Description

Inclusion Criteria:

  • Community-dwelling older adults of both sexes over 60 years of age.

Exclusion Criteria:

  • Those who do not understand the orders given to them by the researcher or present an obvious advanced state of dementia.
  • Those people who have amputation in one of the two upper limbs or who cannot perform manual grasping for any reason.
  • Those who have had an episode of pain in one of the hands during the week prior to the measurement.
  • Those who, due to any illness, prevent or contraindicate maximum resistance exercises.
  • Any other cause that the research team assesses that may affect the results.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Device 1, Device 2 and Jamar®
As this is a validation study, both criterion, inter-observer and intra-observer validation will be performed. Initially, three repetitions will be performed with each device, leaving between 3 and 5 minutes of rest between devices. 20-30 minutes later, the same process will be repeated but with another researcher giving the orders (interobserver reliability). A few days later the same process is repeated with the first investigator (intra-observer reliability). No person will receive any treatment.
As this is a cross-sectional validation study, there is no intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
2. Hand grip test
Time Frame: 2 weeks
Measurement of hand grip strength using a hand-held dynamometer. Values shall be recorded with all three devices.
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Mass Index (BMI)
Time Frame: 2 weeks
Is a mathematical ratio that associates the mass and the size of an individual BMI = weight / height ^2
2 weeks
4. Appendicular Skeletal Muscle mass Index (SMI)
Time Frame: 2 weeks
Is a mathematical ratio that associates the muscle mass and the size of an individual SMI = appendicular muscle mass / height ^2
2 weeks
30 seconds chair stand test (30sCS)
Time Frame: 2 weeks
Test that measures the number of times you perform the maximum number of squats on a chair in 30 seconds. The more squats the better functionally.
2 weeks
Fatigue resistance (FR)
Time Frame: 2 weeks
Time taken to lose 50% of the maximum recorded grip strength.
2 weeks
Grip work (GW)
Time Frame: 2 weeks
Value resulting from multiplying the maximum grip force by the fatigue strength by 0,75. It is measured in watts.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luis Polo-Ferrero, PhD, University of Salamanca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 16, 2024

Primary Completion (Actual)

March 31, 2025

Study Completion (Actual)

April 15, 2025

Study Registration Dates

First Submitted

September 19, 2024

First Submitted That Met QC Criteria

September 29, 2024

First Posted (Actual)

October 2, 2024

Study Record Updates

Last Update Posted (Actual)

December 18, 2025

Last Update Submitted That Met QC Criteria

December 10, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on Validation and reliability

Subscribe